Close Menu

NEW YORK (GenomeWeb) – Biocept today priced its public offering of 6.25 million shares of its common stock and warrants to purchase up to 6.25 million shares of the common stock.

Each share of stock is being sold with one warrant to purchase one share of common stock at a combined price of $1.20 per share and warrant. Gross proceeds from the offering are expected to be about $7.5 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.